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Development of the PREMature Infant Index (PREMIITM), a clinician-
reported outcome measure assessing functional status of extremely preterm 
infants 
ABSTRACT 
Background: Comprehensive measures to evaluate the effectiveness of medical interventions 
in extremely preterm infants are lacking. Although length of stay is used as an indicator of 
overall health among preterm infants in clinical studies, it is confounded by nonmedical 
factors (e.g., parental readiness and availability of home nursing support).
Objectives: To develop the PREMature Infant Index (PREMIITM), an electronic content-valid 
clinician-reported outcome measure for assessing functional status of extremely preterm 
infants (<28 weeks gestational age) serially over time in the neonatal intensive care unit. We 
report the development stages of the PREMII, including suggestions for scoring.
Methods: We developed the PREMII according to US Food and Drug Administration 
regulatory standards. Development included five stages: (1) literature review, (2) clinical 
expert interviews, (3) Delphi panel survey, (4) development of items/levels, and (5) cognitive 
interviews/usability testing. Scoring approaches were explored via an online clinician survey.
Results: Key factors reflective of functional status were identified by physicians and nurses 
during development of the PREMII, as were levels within each factor to assess functional 
status. The resulting PREMII evaluates eight infant health factors: respiratory support, oxygen 
administration, apnea, bradycardia, desaturation, thermoregulation, feeding, and weight gain, 
each scored with three to six gradations. Factor levels are standardized on a 0–100 scale; 
resultant scores are 0–100. No usability issues were identified. The online clinician survey 
identified optimal scoring methods to capture functional status at a given time point.  
Conclusions: Our findings support the content validity and usability of the PREMII as a 
multi-function outcome measure to assess functional status over time in extremely preterm 
infants. Psychometric validation is ongoing.
Key words (5–6): Clinician-reported outcome measure; extremely premature; functional 
status; infant; outcome assessment 
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Survival of infants born extremely preterm, defined as birth at <28 weeks gestational age 
(GA) by the World Health Organization, and used interchangeably with extremely low 
gestational age newborn (ELGAN), has improved over time [1,2]. The majority of extremely 
preterm infants require intensive care in the neonatal period [3], and survivors remain at risk 
of short- and long-term morbidities, such as intraventricular hemorrhage, necrotizing 
enterocolitis (NEC), chronic lung disease, and neurodevelopmental impairment [4-7].  
A challenge for this patient population is the lack of outcome measures to evaluate 
treatment effects in clinical studies, and clinical assessment tools that monitor how the 
neonates grow and mature over time. While length of stay (LOS) is often used as an outcome 
measure in clinical studies, LOS can be influenced by nonmedical factors such as parental 
readiness and availability of home nursing support [8], and institutional variations in 
organization of care [9], thus limiting the appropriateness of LOS as a measure of infant 
health and development and as an endpoint in clinical trials. Existing neonatal illness 
measures, developed primarily to predict mortality and morbidity, combine neonatal data 
shortly after admission to the neonatal intensive care unit (NICU) and not over time. For 
example, the Score for Neonatal Acute Physiology (SNAP) [10] and SNAP Perinatal 
Extension Version II (SNAPPE-II) collect infant data within 24 h and 12 h of admission, 
respectively [11], while the Clinical Risk Index for Babies (CRIB) [12] and CRIB II collect 
data within 12 h and 1 h of admission, respectively, to evaluate risk for mortality [13].
The aim of this study was to develop a comprehensive content-valid clinician-
reported outcome (ClinRO) measure, the PREMature Infant Index (PREMIITM), to assess the 
functional status of extremely preterm infants (<28 weeks GA) over time in the NICU, for 
use in a phase 2 clinical trial. In the current article, we report on the development of the 
PREMII.
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Development of the PREMII followed US Food and Drug Administration regulatory 
guidance for patient-reported outcome instruments [14]—standards that apply to other 
clinical outcome assessment tools, including ClinROs. The PREMII development process 
(phase 1) consisted of five stages: (1) targeted literature review, (2) clinical expert interviews, 
(3) Delphi panel survey, (4) development of PREMII items and levels, and (5) cognitive 
interviews and usability testing of the electronic version. These stages were designed to 
provide evidence of content validity (i.e., relevance, clarity, and comprehensiveness) of the 
PREMII to measure accurately the clinical condition, specifically functional status as it 
changes over time, of the target population (i.e., extremely preterm infants). Additionally, an 
online clinician survey was conducted to explore potential approaches to scoring the 
PREMII.  
Concept of interest
The concept of interest that the PREMII is designed to measure is functional status. 
Functional status is defined as an indicator of neonates’ overall health and development 
encompassing physical, physiological, and clinical status—specifically, what an infant can do 
and what support the infant requires, on a day-to-day basis, as a reflection of their overall 
health and development, which can be also considered as maturation over time. Functional 
status can be assessed with respect to eight key functional areas included in the PREMII 
(feeding, weight gain, thermoregulation, respiratory support, apnea, bradycardia, desaturation 
[ABD] events, and oxygen administration). The PREMII can measure functional status as it 
changes over time with the baby’s development.
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The original target concept for the study was discharge readiness. However, evidence 
gathered from the literature review and clinical expert interviews highlighted challenges to 
standardizing assessment of physical readiness for discharge. These included variability in 
standards of neonatal care, home medical support, and proximity and availability of 
outpatient support. Therefore, the target concept evolved to functional status, which is 
independent of the health care system or home situation. 
Stage 1: targeted literature review
A targeted literature review was undertaken to identify relevant concepts for inclusion in the 
PREMII. We searched Embase, MEDLINE, and PubMed for English-language articles 
published from 2001 to 2015. The search strategy used search terms relevant to factors, 
attributes, and measures related to physical discharge readiness and LOS for extremely 
preterm infants (Supplementary Tables 1–2). 
Stage 2: clinical expert interviews
Telephone semistructured qualitative interviews were conducted. Criteria for inclusion 
included specialized training in neonatology, with ≥10 years of experience caring for preterm 
infants (Table 1). The interviews were designed to obtain feedback from clinicians on the 
physical factors infants need to achieve to be considered ready for NICU discharge, as 
identified by the literature review. See Supplementary Table S3 for an overview of the 
interview questions. 
Stage 3: Delphi panel survey
The Delphi method is a structured communication technique that involves participants (in this 
case, a panel of experts) who answer a questionnaire in an iterative manner after being 
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provided with an anonymized summary of group responses [15]. Participants were asked to 
rate the relative importance of factors, identified through the literature review and clinical 
expert interviews, for the assessment of functional status on a scale of 0 (not at all important) 
to 5 (extremely important). Additionally, participants were asked to provide feedback on the 
definitions of the levels for each factor, as well as other important aspects related to the 
factors and level definitions. The levels for each factor were intended to reflect a scale of 
functional status from very poor to very good. The purpose was to build consensus on the 
most important factors for evaluation of a preterm infant’s functional status for inclusion in 
the PREMII, and to determine the importance of factors.
Stage 4: development of PREMII items and levels
This stage refers to the drafting of the instrument, namely, the formulation of instructions, 
items or questions capturing each of the identified factors relevant in assessing infant 
functional status, and response options.
Stage 5: cognitive interviews and usability testing of the electronic version
Note: cognitive interviews and the online clinician survey occurred in parallel.
Semistructured telephone interviews were conducted in two rounds. The purpose of 
the cognitive interviews was to assess the clarity of the instructions, items, and levels, as well 
as ease of completion of the instrument. Additionally, the interviews were designed to elicit 
any potential logistical difficulties with completing the instrument (e.g., due to nursing shift 
patterns, and differences in geographical or institutional NICU practices). Usability testing of 
the electronic version was undertaken via interviews to assess the ease of completion on an 
electronic device (e.g., a tablet device).  
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The online survey was developed to explore the most appropriate scoring method to capture 
accurately a preterm infant’s functional status at a given time point during their NICU stay. A 
detailed description of the online clinician survey is provided in Appendix 1.
The online survey included questions designed to explore the following: the best approach to 
calculate daily factor scores, the relative importance of each factor in rating an infant’s 
overall functional status, and the best approach to calculate a weekly summary score. The 
questions were based on sample infant profiles that were presented to respondents.
Daily factor scores
Participants were presented with example individual factor ratings for each shift over 
a 24-h period and asked for their opinion on the optimal method to calculate a daily factor 
score from the shift ratings from the following options: the “most frequent” score across shift 
scores provided over the 24-h evaluation period, the “numerical average” score across shift 
scores provided over the 24-h evaluation period, the “worst” (or “best,” as applicable) shift 
score during that period, the “most recent” shift score during that period, or “other” (with a 
request to provide details). Respondents were not asked for a preferred method for calculating 
a daily weight factor score, as weight is not measured repeatedly across shifts.
Relative importance in rating overall functional status
Participants were asked to rate the relative importance (on a scale of 1 [most 
important] to 8 [least important]) of each factor in rating an infant’s functional status; 
respondents were allowed to equally rate multiple factors. Respondents were presented with 
eight clinical examples of infants and their overall functional status scores over a seven-day 
period. The overall functional status scores were summarized as the infant’s most frequent, 
worst (or best), average, and today’s score, as well as the trend over the last three days ratings 
recorded over the seven-day evaluation period. 
Page 7 of 83
URL: http://mc.manuscriptcentral.com/djmf  Email: direnzo@unipg.it

































































Respondents were asked to rate the weekly summary functional status of the infant 
(very poor, poor, moderate, good, very good). Additionally, they were asked to rate the 
importance of each rating approach.
The survey was developed in English and then translated into the following 
languages: Spanish (Spain, Latin America), French (France), German (Germany), Italian 
(Italy), Portuguese (Brazil), and Japanese (Japan). Translations met the requirements of the 
ISO 17100 standard.
Data analysis
Data are reported as descriptive statistics (n and percentage, mean, median). For the clinical 
expert interviews and cognitive interviews, data were analyzed using qualitative methods. For 
the online clinician survey, a linear regression analysis was performed to compare weekly 
summary PREMII scores (“most frequent,” “worst,” “average,” ”today,” “trend [past three 
days]”) with the actual weekly scores provided by the respondents (“weekly summary 
functional status”) for the online infant profiles.
Results
Stage 1: targeted literature review
In total, 998 unique abstracts were identified, of which 48 duplicates were excluded. An 
additional 918 publications were excluded based on predefined exclusion criteria (Figure 1). 
A total of 32 full-text articles were assessed for eligibility, of which nine were excluded for 
lack of relevance. The remaining 23 articles were included in the analysis: 19 related to 
discharge readiness or LOS (original target concept) [9,16-33] (Table 2), three discussed 
instruments for assessing infant mortality/morbidity risk [11,17,34] (Supplementary Table 4; 
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one of these reported findings relevant to both LOS and instruments) [17], and two reported 
national guidelines on the care of preterm/high-risk infants [8,35] (Supplementary Table 5). 
No measures specifically assessing physical readiness for discharge were identified. From the 
included literature, over one-half of the articles noted the infant’s cardiorespiratory stability 
and weight or ability to gain weight as key factors in determining discharge readiness or LOS 
(Table 2). 
Stage 2: clinical expert interviews
Four expert neonatologists (RMW [United States], MAT [United Kingdom], IH-P [Sweden], 
JH [United States]) participated (Supplementary Table 6). The findings were similar to those 
identified in the literature, namely, oral feeding ability, consistent weight gain, 
physical/physiological stability, respiratory stability (e.g., absence of apnea), and 
thermostability (capacity to maintain normal temperature; Table 3). Additionally, two clinical 
experts noted retinopathy of prematurity (one each in relation to discharge readiness and 
LOS).
 
Stage 3: Delphi panel survey
In total, 17 neonatologists participated in the Delphi panel survey (Supplementary Table 6). 
In order of importance, participants endorsed respiratory status, ABD events, feeding ability, 
oxygen supplementation, thermoregulation, and weight gain (Figure 2). Retinopathy of 
prematurity was originally included but subsequently removed, as it was not considered to 
fall under the definition of functional status. 
Feedback from the Delphi survey highlighted perceived differences in the relative 
importance of each ABD event in evaluating functional status, and underlined the need to 
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separate ABD events into individual factors due to potential different underlying physiologic 
causes of events. 
Stage 4: development of the PREMII items and levels
The draft PREMII was developed based on the factors identified in the previous development 
stages, with further rounds of review by the four clinical experts to refine levels within each 
factor. Items included in the first version of the PREMII included weight gain, feeding 
ability, temperature, respiratory support, a single ABD item, and extent of oxygen 
supplementation. 
Stage 5: cognitive interviews and usability testing of the electronic version
The first round of interviews was completed by 23 physicians and nurses; the second round 
was completed by nine nurses (Supplementary Table 6). Each of the PREMII items’ levels 
underwent revisions based on findings from the interviews (Table 4). No issues relating to 
usability of the electronic version of the instrument were identified among the five nurses 
who participated in usability interviews.
Online clinician survey
The online survey was completed by 201 pediatricians and neonatologists (Supplementary 
Table 6). The “numerical average” score across the 24-h evaluation period was the most 
frequently reported preferred method for calculating daily factor scores for each of the seven 
applicable factors (respiratory support, oxygen administration, apnea, bradycardia, 
desaturation, thermoregulation, and feeding; weight gain was excluded from this analysis 
because weight is not measured repeatedly across nursing shifts; Supplementary Figure 1). In 
calculating a weekly summary score, the “trend” score over the past three days and “today’s” 
score were most commonly reported to be most important in determining an infant’s overall 
Page 10 of 83
URL: http://mc.manuscriptcentral.com/djmf  Email: direnzo@unipg.it





























































For Peer Review Only
PREMII Development
11
functional status (53.0% and 34.7%, respectively), based on the previous seven-day period 
using hypothetical infant profiles. With regard to relative importance, on a scale of 1–8 (most 
to least important), respiratory support, apnea, and bradycardia were considered the most 
important of the eight factors (weight included in the assessment) in rating an infant’s 
functional status (Supplementary Figure 2). However, there was variability among physicians 
in terms of relative importance of the factors.
Finalization of instrument
The resulting PREMII comprises eight items capturing each of the identified relevant factors 
(respiratory support, oxygen administration, apnea, bradycardia, desaturation, 
thermoregulation, feeding, and weight gain), each scored on three to six levels, representing a 
scale of functional status ranging from very poor to very good (Appendix). The assessment is 
intended to be repeated over the course of a study to capture change. The intended frequency 
of administration of the PREMII during a Takeda-sponsored clinical trial is described here. 
The PREMII assessment will start ≥48 h after birth on the day the infant reaches the next 
postmenstrual age (PMA) week. For example, if the infant is born at 23 weeks + 4 days, 
PREMII assessment will begin at 24 weeks PMA, but if an infant is born at 23 weeks + 5 
days, PREMII assessment will begin the following PMA week at 25 weeks PMA. In the 
clinical trial, the PREMII will be administered weekly until 32 weeks PMA and then daily 
until discharge or 40 weeks PMA, whichever is the earliest. The nurse primarily responsible 
for the infants’ care will score the PREMII on a tablet device near the end of each nursing 
shift. The PREMII captures a 24-h period and the number of PREMII assessments carried out 
during this time will depend on the duration of nursing shifts (e.g., 8 h or 12 h). Formal 
training will be provided for PREMII users before using the tool. 
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We developed the PREMII, a ClinRO with evidence of content validity, designed to measure 
treatment benefit in clinical trials by assessing the functional status of extremely preterm 
infants in the NICU. To our knowledge, the PREMII is the first comprehensive multi-
function outcome measure developed to capture and measure health and development 
repeatedly in extremely preterm infants over time from birth until discharge from the NICU. 
While illness severity scores are available for the purpose of predicting mortality and 
morbidity [10-13], they primarily collect infant data within 24 h of admission to the NICU, 
and are not designed to assess the process of development and maturation over time. LOS is 
considered an important outcome measure in clinical studies; however, using LOS to assess 
treatment effect in neonatal studies can be challenging on account of factors not directly 
related to infant health that may influence time to discharge, such as parental readiness and 
organizational factors [8,9]. The PREMII includes eight infant health factors (respiratory 
support, oxygen administration, apnea, bradycardia, desaturation, thermoregulation, feeding, 
and weight gain), which will enable the assessment of functional status as an outcome 
measure in neonatal studies, thus providing a comprehensive approach to comparing groups 
of infants, for example, when examining the effects of treatments. 
The development stages demonstrated that the PREMII adequately measures 
functional status in extremely preterm infants and therefore has good content validity, which 
is in accordance with US FDA regulatory standards for developing patient-reported outcome 
instruments [14]. Development of the PREMII was guided by neonatologists and NICU 
nurses, who provided their opinions based on clinical experience. Through the Delphi 
approach, expert neonatologists reached consensus agreement on the factors for inclusion in 
the PREMII, and the importance of factors. An example of this was the consensus that 
respiratory status and the level of support required would adequately measure the severity of 
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lung disease. Participants represented countries across a number of global regions, including 
North America, Europe, Latin America, and Asia-Pacific. This approach highlighted cultural 
differences in clinical practice across regions and aided the development of the PREMII to 
maximize applicability. Although designed for clinical trials, the PREMII could be used as a 
key performance indicator in NICUs, for benchmarking between sites/hospitals, or to adjust 
for illness severity as extremely preterm infants approach term equivalent age. The tool may 
even provide a structured approach to informing discharge readiness by providing the 
relevant data to inform discharge decision making. It should be noted, however, that the 
PREMII is not specifically intended to predict discharge readiness or LOS, but rather to 
assess functional status over time. Furthermore, although the PREMII was developed 
specifically for the population of extremely preterm infants (<28 weeks GA), it could be 
applied to infants born at other GA during their growth and development in the NICU as the 
factors for assessment will remain consistent. 
There are limitations of the PREMII that should be considered. One is that local 
policies regarding neonatal care may differ (e.g., oxygen saturation limits), as well as 
definitions of what constitutes an event (e.g., apnea or bradycardia). The difficulty of 
controlling for differing standards of care and the potential for variability of practice across 
sites remain a challenge in clinical research. We standardized the factors and level ranges 
captured by PREMII items to the greatest extent by gaining consensus input from expert 
clinicians based on global considerations. Additionally, instructions and training are included 
in the PREMII instrument to minimize variation. A further consideration is the element of 
subjectivity in the clinician responses (e.g., “worst experience”). The development steps were 
designed to ensure appropriate and clear response options, to measure the abilities to respond 
using the response options, and consistency of interpretation across respondents. PREMII 
items and levels were developed with extensive clinical expert input and we expect a high 
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degree of consistency in item interpretation; there remains, however, the possibility that 
interpretation may vary among clinicians. We acknowledge that some factors (e.g. feeding 
and weight gain) can be affected by various comorbidities, such as NEC; this will be further 
explored in a separate study (outlined below). 
A separate real-world, prospective, psychometric validation study is underway to 
assessevaluate the measurementpsychometric properties of the PREMII, including for clinical 
application. Specifically, we will evaluate inter- and intra-rater reliability, construct validity, 
and criterion (i.e. predictive) validity, sensitivity to change, and responder definition. 
Comorbidities, especially those that impact nutrition such as NEC, will be captured in the 
study, and outcomes will be categorized. Additionally, the psychometric validation study will 
further explore the scoring of the PREMII and evaluate the optimal frequency of 
administration of PREMII in real-world clinical practice. The PREMII is designed for use 
from shortly after birth through discharge from the NICU; longer term validation (e.g. at two 
years of age) is challenging owing to variation in clinical practice and patient attrition over 
time. 
In conclusion, the PREMII represents a ClinRO measure with well-supported content 
validity and usability to assess the functional status of extremely preterm infants serially over 
time in the NICU. It is hoped this unique tool will be suitable for use in neonatal clinical 
studies. 
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Table 1. Participant inclusion criteria for the PREMII development stages. 
PREMII development 
stage Participant inclusion criteria
Clinical expert 
interviews
 General medical license or registration, plus a specialty license or 
registration in neonatology, as applicable in country of origin 
 Practicing neonatologist with ≥10 years of experience in the care of 
preterm infants
 Coauthored hospital management guidelines on the care of preterm 
infants or a neonatology-related textbook
 Oral and written fluency in English
 Availability for a 1-h interview and periodic consulting and/or review 
of short documents via email or telephone call throughout the duration 
of the study (~10 months)
Delphi panel survey  General medical license or registration, plus a specialty license or 
registration in neonatology, as applicable in country of origin
 Practicing neonatologist with ≥5 years of experience in the care of 
preterm infants
 Coauthored peer-reviewed publications, hospital management 
guidelines on the care of preterm infants, or neonatology-related 
textbook; was a speaker at conferences or neonatology clinical 
meetings; or acted as a principal investigator/sub-principal investigator 
in any past or present neonatology-related trials
 Oral and written fluency in English
 Availability to complete up to three brief (10- to 15-min) online 
surveys
Cognitive interviews and 
usability testing
 Practicing neonatologist with >5 years of experience in the care of 
preterm infants, or neonatal nurse with >5 years of experience working 
in the NICU
 Oral and written fluency in English
Online survey  General medical license or registration
 Specialist training in pediatrics or neonatology
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 Practicing neonatologist or pediatrician, with responsibilities that 
include the care of preterm infants 
 ≥5 years of experience in the care of preterm infants
 Agreement to complete a 35- to 40-min online survey in English or 
native language of country of origin
NICU: neonatal intensive care unit; PREMII: PREMature Infant Index.
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Table 2. The number of articles reporting physical and nonphysical factors related to 





Weight or weight gain 13 Barone 2014 [16]; Bender 2013 [17]; Eichenwald 2001 
[18]; Gaal 2008 [19]; Hintz 2010 [20]; Jeremic 2008 
[21]; Lee 2013 [22]; Manktelow 2010 [23]; Merritt 2003 
[24]; Picone 2011 [25]; Seki 2011 [26]; Temple 2015 
[27]; Ye 2011 [28]
Cardiorespiratory 
stability
11 Barone 2014 [16]; Berry 2008 [29]; Eichenwald 2001 
[18]; Gaal 2008 [19]; Hintz 2010 [20]; Jeremic 2008 
[21]; Manktelow 2010 [23]; Merritt 2003 [24]; 
Nankervis 2010 [30]; Seki 2011 [26]; Ye 2011 [28]
Oral feeding to support 
growth
7 Barone 2014 [16]; Eichenwald 2001 [18]; Gaal 2008 
[19]; McGrath 2004 [31]; Merritt 2003 [24]; Temple 
2015 [27]; Ye 2011 [28]




5 Barone 2014 [16]; Eichenwald 2001 [18]; Merritt 2003 
[24]; Seki 2011 [26]; Ye 2011 [28]
Nonphysical
Organizational 5 Eichenwald 2001 [18]; Manktelow 2010 [23]; Altman 
2006 [32]; Altman 2009 [9]; Cotten 2005 [33]
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2 Merritt 2003 [24]; Seki 2011 [26]
Parental readiness 1 Picone 2011 [25]
Searches were conducted using databases including Embase, MEDLINE, and PubMed for 
English-language articles published between 2001 and 2015. Search terms included 
prematurity, newborn intensive care, gestational age, scoring systems, guideline, and hospital 
discharge (Supplementary Tables 1–2). 
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Table 3. Key factors influencing discharge from NICU identified by clinical expert 
interviews.
Factor Description
Feeding Ability to feed orally to maintain consistent weight gain
Breathing Stable respirations without positive airway pressure support
Thermostability Ability to maintain normal temperature in open crib/bassinet
Physical/physiological 
stability
Includes absence of the following: apnea, oxygen 
desaturation, and gastrointestinal disturbances, such as 
severe reflux
Retinopathy of prematurity Stable or regressing disease
Nonphysical factors Parental readiness, parental interaction with infant, social 
network support, transportation, home situation, fluency in 
national language/access to translation services for 
communication during follow-up
NICU: neonatal intensive care unit.
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Table 4. Participant feedback from rounds 1 and 2 of the cognitive interviews, and the subsequent revisions made to the PREMII following 
consultation with the clinical experts.
Item Participant feedback Revisions to the PREMII
Round 1  Suggest clarifying “no supplemental oxygen” in last 
level 
 Inclusion of a reference to negative pressure or 
positive pressure
 Definition of high-flow and low-flow oxygen included
 “Intratracheal” not a familiar term
 “Negative pressure support” isn’t commonly used
 Both terms removed
 “Only” doesn’t fit with instructions  Removal of “only” (to ensure that the worst level 
during the shift is selected)
Respiratory support
Round 2
—  “Supplemental oxygen continuously” and “low-flow 
nasal cannula” split into separate levels
 Selection of “low-flow nasal cannula” prompts an 
answer on air source and greatest L/min setting
Oxygen 
administration
Round 1  Levels are clearer if explicit ranges are reported
 Distinction between >50% and <50% is important to 
capture
 Incorporation of additional ranges of percentage 
concentrations
 Inclusion of instruction “report the highest 
concentration during each shift” (to ensure consistent 
and clear interpretation and completion of the item)
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Round 2  Uncertainty on how to rate the item for infants on low-
flow nasal cannula
 Item skipped for infants rated as being on continuous 
low-flow nasal cannula
Round 1  ABD (as one item) should be separated  ABD (as one item) revised to three separate itemsApnea
Round 2  Important to clarify if infant needed intervention or 
not
 Inclusion of “requiring intervention”
Round 1  ABD (as one item) should be separated  ABD (as one item) revised to three separate items
 Definition may change based on gestational age of the 
infant
 No revision made
Bradycardia
Round 2
 “Clinically relevant” may cause confusion  Definitions revised
Round 1  ABD (as one item) should be separated  ABD (as one item) revised to three separate items
 Important to clarify if event requires intervention or is 
self-resolving
 Inclusion of “requiring intervention”
Desaturation
Round 2
 Definition should include “≤”  Inclusion of “≤”
 Need to define “oral feeds” and add/clarify regarding 
enteral feeding 
 Oral feeds defined as feeds via breast or bottleRound 1
 Suggest including reference to feeds via catheter  Inclusion of reference to enteral feeding and catheter
 “Catheter” may cause confusion  “Catheter” removed from feeding levels
Feeding
Round 2
 Need to clarify “no feeds occurred”  “No feed occurred” (originally intended to represent a 
“not applicable” option) removed 
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 Revised to include question on whether feeds 
(including IV or enteral tube feeding) occurred during 
the shift; if “no,” item skipped
Weight gain Round 1  Infants may not be weighed every day  Revised to account for the possibility of no weight 
recorded on a given day
Round 2 — —
  “Bundled” not a clear or familiar term  Examples provided to define “bundled”Round 1
 Need to better highlight differences between levels
 Some words redundant
 Reference to radiant warmer included 
Temperature
Round 2  Statements wordy and too specific  No revision made
ABD: apnea, bradycardia, desaturation; IV: intravenous; PREMII: PREMature Infant Index.
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Figure 1. Literature identification and study selection process for publications included in the 
targeted literature review.
Figure 2. Factors important in the assessment of functional status in order of importance 
rating during Delphi panel survey. 
aFactors were rated on a scale of 0 (not at all important) to 5 (extremely important) and are 
listed in order of strength of endorsement (i.e., from highest mean importance rating to 
lowest). ABD: apnea, bradycardia, desaturation.
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Development of the PREMature Infant Index (PREMIITM), a clinician-
reported outcome measure assessing functional status of extremely preterm 
infants 
ABSTRACT 
Background: Comprehensive measures to evaluate the effectiveness of medical interventions 
in extremely preterm infants are lacking. Although length of stay is used as an indicator of 
overall health among preterm infants in clinical studies, it is confounded by nonmedical 
factors (e.g., parental readiness and availability of home nursing support).
Objectives: To develop the PREMature Infant Index (PREMIITM), an electronic content-valid 
clinician-reported outcome measure for assessing functional status of extremely preterm 
infants (<28 weeks gestational age) serially over time in the neonatal intensive care unit. We 
report the development stages of the PREMII, including suggestions for scoring.
Methods: We developed the PREMII according to US Food and Drug Administration 
regulatory standards. Development included five stages: (1) literature review, (2) clinical 
expert interviews, (3) Delphi panel survey, (4) development of items/levels, and (5) cognitive 
interviews/usability testing. Scoring approaches were explored via an online clinician survey.
Results: Key factors reflective of functional status were identified by physicians and nurses 
during development of the PREMII, as were levels within each factor to assess functional 
status. The resulting PREMII evaluates eight infant health factors: respiratory support, oxygen 
administration, apnea, bradycardia, desaturation, thermoregulation, feeding, and weight gain, 
each scored with three to six gradations. Factor levels are standardized on a 0–100 scale; 
resultant scores are 0–100. No usability issues were identified. The online clinician survey 
identified optimal scoring methods to capture functional status at a given time point.  
Conclusions: Our findings support the content validity and usability of the PREMII as a 
multi-function outcome measure to assess functional status over time in extremely preterm 
infants. Psychometric validation is ongoing.
Key words (5–6): Clinician-reported outcome measure; extremely premature; functional 
status; infant; outcome assessment 
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Introduction
Survival of infants born extremely preterm, defined as birth at <28 weeks gestational age 
(GA) by the World Health Organization, and used interchangeably with extremely low 
gestational age newborn (ELGAN), has improved over time [1,2]. The majority of extremely 
preterm infants require intensive care in the neonatal period [3], and survivors remain at risk 
of short- and long-term morbidities, such as intraventricular hemorrhage, necrotizing 
enterocolitis (NEC), chronic lung disease, and neurodevelopmental impairment [4-7].  
A challenge for this patient population is the lack of outcome measures to evaluate 
treatment effects in clinical studies, and clinical assessment tools that monitor how the 
neonates grow and mature over time. While length of stay (LOS) is often used as an outcome 
measure in clinical studies, LOS can be influenced by nonmedical factors such as parental 
readiness and availability of home nursing support [8], and institutional variations in 
organization of care [9], thus limiting the appropriateness of LOS as a measure of infant 
health and development and as an endpoint in clinical trials. Existing neonatal illness 
measures, developed primarily to predict mortality and morbidity, combine neonatal data 
shortly after admission to the neonatal intensive care unit (NICU) and not over time. For 
example, the Score for Neonatal Acute Physiology (SNAP) [10] and SNAP Perinatal 
Extension Version II (SNAPPE-II) collect infant data within 24 h and 12 h of admission, 
respectively [11], while the Clinical Risk Index for Babies (CRIB) [12] and CRIB II collect 
data within 12 h and 1 h of admission, respectively, to evaluate risk for mortality [13].
The aim of this study was to develop a comprehensive content-valid clinician-
reported outcome (ClinRO) measure, the PREMature Infant Index (PREMIITM), to assess the 
functional status of extremely preterm infants (<28 weeks GA) over time in the NICU, for 
use in a phase 2 clinical trial. In the current article, we report on the development of the 
PREMII.
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Development of the PREMII followed US Food and Drug Administration regulatory 
guidance for patient-reported outcome instruments [14]—standards that apply to other 
clinical outcome assessment tools, including ClinROs. The PREMII development process 
(phase 1) consisted of five stages: (1) targeted literature review, (2) clinical expert interviews, 
(3) Delphi panel survey, (4) development of PREMII items and levels, and (5) cognitive 
interviews and usability testing of the electronic version. These stages were designed to 
provide evidence of content validity (i.e., relevance, clarity, and comprehensiveness) of the 
PREMII to measure accurately the clinical condition, specifically functional status as it 
changes over time, of the target population (i.e., extremely preterm infants). Additionally, an 
online clinician survey was conducted to explore potential approaches to scoring the 
PREMII.  
Concept of interest
The concept of interest that the PREMII is designed to measure is functional status. 
Functional status is defined as an indicator of neonates’ overall health and development 
encompassing physical, physiological, and clinical status—specifically, what an infant can do 
and what support the infant requires, on a day-to-day basis, as a reflection of their overall 
health and development, which can be also considered as maturation over time. Functional 
status can be assessed with respect to eight key functional areas included in the PREMII 
(feeding, weight gain, thermoregulation, respiratory support, apnea, bradycardia, desaturation 
[ABD] events, and oxygen administration). The PREMII can measure functional status as it 
changes over time with the baby’s development.
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The original target concept for the study was discharge readiness. However, evidence 
gathered from the literature review and clinical expert interviews highlighted challenges to 
standardizing assessment of physical readiness for discharge. These included variability in 
standards of neonatal care, home medical support, and proximity and availability of 
outpatient support. Therefore, the target concept evolved to functional status, which is 
independent of the health care system or home situation. 
Stage 1: targeted literature review
A targeted literature review was undertaken to identify relevant concepts for inclusion in the 
PREMII. We searched Embase, MEDLINE, and PubMed for English-language articles 
published from 2001 to 2015. The search strategy used search terms relevant to factors, 
attributes, and measures related to physical discharge readiness and LOS for extremely 
preterm infants (Supplementary Tables 1–2). 
Stage 2: clinical expert interviews
Telephone semistructured qualitative interviews were conducted. Criteria for inclusion 
included specialized training in neonatology, with ≥10 years of experience caring for preterm 
infants (Table 1). The interviews were designed to obtain feedback from clinicians on the 
physical factors infants need to achieve to be considered ready for NICU discharge, as 
identified by the literature review. See Supplementary Table S3 for an overview of the 
interview questions. 
Stage 3: Delphi panel survey
The Delphi method is a structured communication technique that involves participants (in this 
case, a panel of experts) who answer a questionnaire in an iterative manner after being 
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provided with an anonymized summary of group responses [15]. Participants were asked to 
rate the relative importance of factors, identified through the literature review and clinical 
expert interviews, for the assessment of functional status on a scale of 0 (not at all important) 
to 5 (extremely important). Additionally, participants were asked to provide feedback on the 
definitions of the levels for each factor, as well as other important aspects related to the 
factors and level definitions. The levels for each factor were intended to reflect a scale of 
functional status from very poor to very good. The purpose was to build consensus on the 
most important factors for evaluation of a preterm infant’s functional status for inclusion in 
the PREMII, and to determine the importance of factors.
Stage 4: development of PREMII items and levels
This stage refers to the drafting of the instrument, namely, the formulation of instructions, 
items or questions capturing each of the identified factors relevant in assessing infant 
functional status, and response options.
Stage 5: cognitive interviews and usability testing of the electronic version
Note: cognitive interviews and the online clinician survey occurred in parallel.
Semistructured telephone interviews were conducted in two rounds. The purpose of 
the cognitive interviews was to assess the clarity of the instructions, items, and levels, as well 
as ease of completion of the instrument. Additionally, the interviews were designed to elicit 
any potential logistical difficulties with completing the instrument (e.g., due to nursing shift 
patterns, and differences in geographical or institutional NICU practices). Usability testing of 
the electronic version was undertaken via interviews to assess the ease of completion on an 
electronic device (e.g., a tablet device).  
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Online clinician survey
The online survey was developed to explore the most appropriate scoring method to capture 
accurately a preterm infant’s functional status at a given time point during their NICU stay. 
The online survey included questions designed to explore the following: the best approach to 
calculate daily factor scores, the relative importance of each factor in rating an infant’s 
overall functional status, and the best approach to calculate a weekly summary score. The 
questions were based on sample infant profiles that were presented to respondents.
Daily factor scores
Participants were presented with example individual factor ratings for each shift over 
a 24-h period and asked for their opinion on the optimal method to calculate a daily factor 
score from the shift ratings from the following options: the “most frequent” score across shift 
scores provided over the 24-h evaluation period, the “numerical average” score across shift 
scores provided over the 24-h evaluation period, the “worst” (or “best,” as applicable) shift 
score during that period, the “most recent” shift score during that period, or “other” (with a 
request to provide details). Respondents were not asked for a preferred method for calculating 
a daily weight factor score, as weight is not measured repeatedly across shifts.
Relative importance in rating overall functional status
Participants were asked to rate the relative importance (on a scale of 1 [most 
important] to 8 [least important]) of each factor in rating an infant’s functional status; 
respondents were allowed to equally rate multiple factors. Respondents were presented with 
eight clinical examples of infants and their overall functional status scores over a seven-day 
period. The overall functional status scores were summarized as the infant’s most frequent, 
worst (or best), average, and today’s score, as well as the trend over the last three days ratings 
recorded over the seven-day evaluation period. 
Weekly summary score
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Respondents were asked to rate the weekly summary functional status of the infant 
(very poor, poor, moderate, good, very good). Additionally, they were asked to rate the 
importance of each rating approach.
The survey was developed in English and then translated into the following 
languages: Spanish (Spain, Latin America), French (France), German (Germany), Italian 
(Italy), Portuguese (Brazil), and Japanese (Japan). Translations met the requirements of the 
ISO 17100 standard.
Data analysis
Data are reported as descriptiv  statistics (n and percentage, mean, median). For the clinical 
expert interviews and cognitive interviews, data were analyzed using qualitative methods. For 
the online clinician survey, a linear regression analysis was performed to compare weekly 
summary PREMII scores (“most frequent,” “worst,” “average,” ”today,” “trend [past three 
days]”) with the actual weekly scores provided by the respondents (“weekly summary 
functional status”) for the online infant profiles.
Results
Stage 1: targeted literature review
In total, 998 unique abstracts were identified, of which 48 duplicates were excluded. An 
additional 918 publications were excluded based on predefined exclusion criteria (Figure 1). 
A total of 32 full-text articles were assessed for eligibility, of which nine were excluded for 
lack of relevance. The remaining 23 articles were included in the analysis: 19 related to 
discharge readiness or LOS (original target concept) [9,16-33] (Table 2), three discussed 
instruments for assessing infant mortality/morbidity risk [11,17,34] (Supplementary Table 4; 
one of these reported findings relevant to both LOS and instruments) [17], and two reported 
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national guidelines on the care of preterm/high-risk infants [8,35] (Supplementary Table 5). 
No measures specifically assessing physical readiness for discharge were identified. From the 
included literature, over one-half of the articles noted the infant’s cardiorespiratory stability 
and weight or ability to gain weight as key factors in determining discharge readiness or LOS 
(Table 2). 
Stage 2: clinical expert interviews
Four expert neonatologists (RMW [United States], MAT [United Kingdom], IH-P [Sweden], 
JH [United States]) participated (Supplementary Table 6). The findings were similar to those 
identified in the literature, nam ly, oral feeding ability, consistent weight gain, 
physical/physiological stability, respiratory stability (e.g., absence of apnea), and 
thermostability (capacity to maintain normal temperature; Table 3). Additionally, two clinical 
experts noted retinopathy of prematurity (one each in relation to discharge readiness and 
LOS).
 
Stage 3: Delphi panel survey
In total, 17 neonatologists participated in the Delphi panel survey (Supplementary Table 6). 
In order of importance, participants endorsed respiratory status, ABD events, feeding ability, 
oxygen supplementation, thermoregulation, and weight gain (Figure 2). Retinopathy of 
prematurity was originally included but subsequently removed, as it was not considered to 
fall under the definition of functional status. 
Feedback from the Delphi survey highlighted perceived differences in the relative 
importance of each ABD event in evaluating functional status, and underlined the need to 
separate ABD events into individual factors due to potential different underlying physiologic 
causes of events. 
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Stage 4: development of the PREMII items and levels
The draft PREMII was developed based on the factors identified in the previous development 
stages, with further rounds of review by the four clinical experts to refine levels within each 
factor. Items included in the first version of the PREMII included weight gain, feeding 
ability, temperature, respiratory support, a single ABD item, and extent of oxygen 
supplementation. 
Stage 5: cognitive interviews and usability testing of the electronic version
The first round of interviews was completed by 23 physicians and nurses; the second round 
was completed by nine nurses (Supplementary Table 6). Each of the PREMII items’ levels 
underwent revisions based on findings from the interviews (Table 4). No issues relating to 
usability of the electronic version of the instrument were identified among the five nurses 
who participated in usability interviews.
Online clinician survey
The online survey was completed by 201 pediatricians and neonatologists (Supplementary 
Table 6). The “numerical average” score across the 24-h evaluation period was the most 
frequently reported preferred method for calculating daily factor scores for each of the seven 
applicable factors (respiratory support, oxygen administration, apnea, bradycardia, 
desaturation, thermoregulation, and feeding; weight gain was excluded from this analysis 
because weight is not measured repeatedly across nursing shifts; Supplementary Figure 1). In 
calculating a weekly summary score, the “trend” score over the past three days and “today’s” 
score were most commonly reported to be most important in determining an infant’s overall 
functional status (53.0% and 34.7%, respectively), based on the previous seven-day period 
using hypothetical infant profiles. With regard to relative importance, on a scale of 1–8 (most 
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to least important), respiratory support, apnea, and bradycardia were considered the most 
important of the eight factors (weight included in the assessment) in rating an infant’s 
functional status (Supplementary Figure 2). However, there was variability among physicians 
in terms of relative importance of the factors.
Finalization of instrument
The resulting PREMII comprises eight items capturing each of the identified relevant factors 
(respiratory support, oxygen administration, apnea, bradycardia, desaturation, 
thermoregulation, feeding, and weight gain), each scored on three to six levels, representing a 
scale of functional status ranging from very poor to very good (Appendix). The assessment is 
intended to be repeated over the course of a study to capture change. The intended frequency 
of administration of the PREMII during a Takeda-sponsored clinical trial is described here. 
The PREMII assessment will start ≥48 h after birth on the day the infant reaches the next 
postmenstrual age (PMA) week. For example, if the infant is born at 23 weeks + 4 days, 
PREMII assessment will begin at 24 weeks PMA, but if an infant is born at 23 weeks + 5 
days, PREMII assessment will begin the following PMA week at 25 weeks PMA. In the 
clinical trial, the PREMII will be administered weekly until 32 weeks PMA and then daily 
until discharge or 40 weeks PMA, whichever is the earliest. The nurse primarily responsible 
for the infants’ care will score the PREMII on a tablet device near the end of each nursing 
shift. The PREMII captures a 24-h period and the number of PREMII assessments carried out 
during this time will depend on the duration of nursing shifts (e.g., 8 h or 12 h). Formal 
training will be provided for PREMII users before using the tool. 
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Discussion
We developed the PREMII, a ClinRO with evidence of content validity, designed to measure 
treatment benefit in clinical trials by assessing the functional status of extremely preterm 
infants in the NICU. To our knowledge, the PREMII is the first comprehensive multi-
function outcome measure developed to capture and measure health and development 
repeatedly in extremely preterm infants over time from birth until discharge from the NICU. 
While illness severity scores are available for the purpose of predicting mortality and 
morbidity [10-13], they primarily collect infant data within 24 h of admission to the NICU, 
and are not designed to assess the process of development and maturation over time. LOS is 
considered an important outcome measure in clinical studies; however, using LOS to assess 
treatment effect in neonatal studies can be challenging on account of factors not directly 
related to infant health that may influence time to discharge, such as parental readiness and 
organizational factors [8,9]. The PREMII includes eight infant health factors (respiratory 
support, oxygen administration, apnea, bradycardia, desaturation, thermoregulation, feeding, 
and weight gain), which will enable the assessment of functional status as an outcome 
measure in neonatal studies, thus providing a comprehensive approach to comparing groups 
of infants, for example, when examining the effects of treatments. 
The development stages demonstrated that the PREMII adequately measures 
functional status in extremely preterm infants and therefore has good content validity, which 
is in accordance with US FDA regulatory standards for developing patient-reported outcome 
instruments [14]. Development of the PREMII was guided by neonatologists and NICU 
nurses, who provided their opinions based on clinical experience. Through the Delphi 
approach, expert neonatologists reached consensus agreement on the factors for inclusion in 
the PREMII, and the importance of factors. An example of this was the consensus that 
respiratory status and the level of support required would adequately measure the severity of 
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lung disease. Participants represented countries across a number of global regions, including 
North America, Europe, Latin America, and Asia-Pacific. This approach highlighted cultural 
differences in clinical practice across regions and aided the development of the PREMII to 
maximize applicability. Although designed for clinical trials, the PREMII could be used as a 
key performance indicator in NICUs, for benchmarking between sites/hospitals, or to adjust 
for illness severity as extremely preterm infants approach term equivalent age. The tool may 
even provide a structured approach to informing discharge readiness by providing the 
relevant data to inform discharge decision making. It should be noted, however, that the 
PREMII is not specifically intended to predict discharge readiness or LOS, but rather to 
assess functional status over time. Furthermore, although the PREMII was developed 
specifically for the population of extremely preterm infants (<28 weeks GA), it could be 
applied to infants born at other GA during their growth and development in the NICU as the 
factors for assessment will remain consistent. 
There are limitations of the PREMII that should be considered. One is that local 
policies regarding neonatal care may differ (e.g., oxygen saturation limits), as well as 
definitions of what constitutes an event (e.g., apnea or bradycardia). The difficulty of 
controlling for differing standards of care and the potential for variability of practice across 
sites remain a challenge in clinical research. We standardized the factors and level ranges 
captured by PREMII items to the greatest extent by gaining consensus input from expert 
clinicians based on global considerations. Additionally, instructions and training are included 
in the PREMII instrument to minimize variation. A further consideration is the element of 
subjectivity in the clinician responses (e.g., “worst experience”). The development steps were 
designed to ensure appropriate and clear response options, to measure the abilities to respond 
using the response options, and consistency of interpretation across respondents. PREMII 
items and levels were developed with extensive clinical expert input and we expect a high 
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degree of consistency in item interpretation; there remains, however, the possibility that 
interpretation may vary among clinicians. We acknowledge that some factors (e.g. feeding 
and weight gain) can be affected by various comorbidities, such as NEC; this will be further 
explored in a separate study (outlined below). 
A separate real-world, prospective, psychometric validation study is underway to 
evaluate the psychometric properties of the PREMII for clinical application. Specifically, we 
will evaluate inter- and intra-rater reliability, construct validity, criterion (i.e. predictive) 
validity, sensitivity to change, and responder definition. Comorbidities, especially those that 
impact nutrition such as NEC, will be captured in the study, and outcomes will be 
categorized. Additionally, the psychometric validation study will further explore the scoring 
of the PREMII and evaluate the optimal frequency of administration of PREMII in real-world 
clinical practice. The PREMII is designed for use from shortly after birth through discharge 
from the NICU; longer term validation (e.g. at two years of age) is challenging owing to 
variation in clinical practice and patient attrition over time. 
In conclusion, the PREMII represents a ClinRO measure with well-supported content 
validity and usability to assess the functional status of extremely preterm infants serially over 
time in the NICU. It is hoped this unique tool will be suitable for use in neonatal clinical 
studies. 
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Table 1. Participant inclusion criteria for the PREMII development stages. 
PREMII development 
stage Participant inclusion criteria
Clinical expert 
interviews
 General medical license or registration, plus a specialty license or 
registration in neonatology, as applicable in country of origin 
 Practicing neonatologist with ≥10 years of experience in the care of 
preterm infants
 Coauthored hospital management guidelines on the care of preterm 
infants or a neonatology-related textbook
 Oral and written fluency in English
 Availability for a 1-h interview and periodic consulting and/or review 
of short documents via email or telephone call throughout the duration 
of the study (~10 months)
Delphi panel survey  General medical license or registration, plus a specialty license or 
registration in neonatology, as applicable in country of origin
 Practicing neonatologist with ≥5 years of experience in the care of 
preterm infants
 Coauthored peer-reviewed publications, hospital management 
guidelines on the care of preterm infants, or neonatology-related 
textbook; was a speaker at conferences or neonatology clinical 
meetings; or acted as a principal investigator/sub-principal investigator 
in any past or present neonatology-related trials
 Oral and written fluency in English
 Availability to complete up to three brief (10- to 15-min) online 
surveys
Cognitive interviews and 
usability testing
 Practicing neonatologist with >5 years of experience in the care of 
preterm infants, or neonatal nurse with >5 years of experience working 
in the NICU
 Oral and written fluency in English
Online survey  General medical license or registration
 Specialist training in pediatrics or neonatology
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 Practicing neonatologist or pediatrician, with responsibilities that 
include the care of preterm infants 
 ≥5 years of experience in the care of preterm infants
 Agreement to complete a 35- to 40-min online survey in English or 
native language of country of origin
NICU: neonatal intensive care unit; PREMII: PREMature Infant Index.
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Table 2. The number of articles reporting physical and nonphysical factors related to 





Weight or weight gain 13 Barone 2014 [16]; Bender 2013 [17]; Eichenwald 2001 
[18]; Gaal 2008 [19]; Hintz 2010 [20]; Jeremic 2008 
[21]; Lee 2013 [22]; Manktelow 2010 [23]; Merritt 2003 
[24]; Picone 2011 [25]; Seki 2011 [26]; Temple 2015 
[27]; Ye 2011 [28]
Cardiorespiratory 
stability
11 Barone 2014 [16]; Berry 2008 [29]; Eichenwald 2001 
[18]; Gaal 2008 [19]; Hintz 2010 [20]; Jeremic 2008 
[21]; Manktelow 2010 [23]; Merritt 2003 [24]; 
Nankervis 2010 [30]; Seki 2011 [26]; Ye 2011 [28]
Oral feeding to support 
growth
7 Barone 2014 [16]; Eichenwald 2001 [18]; Gaal 2008 
[19]; McGrath 2004 [31]; Merritt 2003 [24]; Temple 
2015 [27]; Ye 2011 [28]




5 Barone 2014 [16]; Eichenwald 2001 [18]; Merritt 2003 
[24]; Seki 2011 [26]; Ye 2011 [28]
Nonphysical
Organizational 5 Eichenwald 2001 [18]; Manktelow 2010 [23]; Altman 
2006 [32]; Altman 2009 [9]; Cotten 2005 [33]
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2 Merritt 2003 [24]; Seki 2011 [26]
Parental readiness 1 Picone 2011 [25]
Searches were conducted using databases including Embase, MEDLINE, and PubMed for 
English-language articles published between 2001 and 2015. Search terms included 
prematurity, newborn intensive care, gestational age, scoring systems, guideline, and hospital 
discharge (Supplementary Tables 1–2). 
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Table 3. Key factors influencing discharge from NICU identified by clinical expert 
interviews.
Factor Description
Feeding Ability to feed orally to maintain consistent weight gain
Breathing Stable respirations without positive airway pressure support
Thermostability Ability to maintain normal temperature in open crib/bassinet
Physical/physiological 
stability
Includes absence of the following: apnea, oxygen 
desaturation, and gastrointestinal disturbances, such as 
severe reflux
Retinopathy of prematurity Stable or regressing disease
Nonphysical factors Parental readiness, parental interaction with infant, social 
network support, transportation, home situation, fluency in 
national language/access to translation services for 
communication during follow-up
NICU: neonatal intensive care unit.
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Table 4. Participant feedback from rounds 1 and 2 of the cognitive interviews, and the subsequent revisions made to the PREMII following 
consultation with the clinical experts.
Item Participant feedback Revisions to the PREMII
Round 1  Suggest clarifying “no supplemental oxygen” in last 
level 
 Inclusion of a reference to negative pressure or 
positive pressure
 Definition of high-flow and low-flow oxygen included
 “Intratracheal” not a familiar term
 “Negative pressure support” isn’t commonly used
 Both terms removed
 “Only” doesn’t fit with instructions  Removal of “only” (to ensure that the worst level 
during the shift is selected)
Respiratory support
Round 2
—  “Supplemental oxygen continuously” and “low-flow 
nasal cannula” split into separate levels
 Selection of “low-flow nasal cannula” prompts an 
answer on air source and greatest L/min setting
Oxygen 
administration
Round 1  Levels are clearer if explicit ranges are reported
 Distinction between >50% and <50% is important to 
capture
 Incorporation of additional ranges of percentage 
concentrations
 Inclusion of instruction “report the highest 
concentration during each shift” (to ensure consistent 
and clear interpretation and completion of the item)
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Round 2  Uncertainty on how to rate the item for infants on low-
flow nasal cannula
 Item skipped for infants rated as being on continuous 
low-flow nasal cannula
Round 1  ABD (as one item) should be separated  ABD (as one item) revised to three separate itemsApnea
Round 2  Important to clarify if infant needed intervention or 
not
 Inclusion of “requiring intervention”
Round 1  ABD (as one item) should be separated  ABD (as one item) revised to three separate items
 Definition may change based on gestational age of the 
infant
 No revision made
Bradycardia
Round 2
 “Clinically relevant” may cause confusion  Definitions revised
Round 1  ABD (as one item) should be separated  ABD (as one item) revised to three separate items
 Important to clarify if event requires intervention or is 
self-resolving
 Inclusion of “requiring intervention”
Desaturation
Round 2
 Definition should include “≤”  Inclusion of “≤”
 Need to define “oral feeds” and add/clarify regarding 
enteral feeding 
 Oral feeds defined as feeds via breast or bottleRound 1
 Suggest including reference to feeds via catheter  Inclusion of reference to enteral feeding and catheter
 “Catheter” may cause confusion  “Catheter” removed from feeding levels
Feeding
Round 2
 Need to clarify “no feeds occurred”  “No feed occurred” (originally intended to represent a 
“not applicable” option) removed 
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 Revised to include question on whether feeds 
(including IV or enteral tube feeding) occurred during 
the shift; if “no,” item skipped
Weight gain Round 1  Infants may not be weighed every day  Revised to account for the possibility of no weight 
recorded on a given day
Round 2 — —
  “Bundled” not a clear or familiar term  Examples provided to define “bundled”Round 1
 Need to better highlight differences between levels
 Some words redundant
 Reference to radiant warmer included 
Temperature
Round 2  Statements wordy and too specific  No revision made
ABD: apnea, bradycardia, desaturation; IV: intravenous; PREMII: PREMature Infant Index.
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Figure 1. Literature identification and study selection process for publications included in the 
targeted literature review.
Figure 2. Factors important in the assessment of functional status in order of importance 
rating during Delphi panel survey. 
aFactors were rated on a scale of 0 (not at all important) to 5 (extremely important) and are 
listed in order of strength of endorsement (i.e., from highest mean importance rating to 
lowest). ABD: apnea, bradycardia, desaturation.
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Figure 2. Factors important in the assessment of functional status in order of importance rating during 
Delphi panel survey. aFactors were rated on a scale of 0 (not at all important) to 5 (extremely important) 
and are listed in order of strength of endorsement (i.e., from highest mean importance rating to lowest). 
ABD: apnea, bradycardia, desaturation. 
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1 exp prematurity/ or exp newborn intensive care/ or exp gestational age/ 174,535
2 exp scoring system/ or exp gestational age/ or exp newborn intensive care/ 
or *mortality/ or Score for Neonatal Acute Physiology.mp. or exp 
prematurity/ or exp very low birth weight/
433,189
3 (SNAP or SNAP-II or SNAPPE-II).mp. [mp=title, abstract, heading word, 
drug trade name, original title, device manufacturer, drug manufacturer, 
device trade name, keyword]
11,262
4 exp hospital discharge/ 75,321
5 (guideline$ or factor$).mp. [mp=title, abstract, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade 
name, keyword]
4,378,844
6 (Benchmarking or Quality Control).mp. [mp=title, abstract, heading word, 
drug trade name, original title, device manufacturer, drug manufacturer, 
device trade name, keyword]
165,380
7 (Projection$ or Prediction$).mp. [mp=title, abstract, heading word, drug 
trade name, original title, device manufacturer, drug manufacturer, device 
trade name, keyword]
526,088
8 (Neonate or Preterm Infant or Premature Infant).mp. [mp=title, abstract, 
heading word, drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword]
42,190
9 or/5–7 4,901,511
10 4 and 9 20,122
11 2 and 3 and 10 4
12 4 and 7 and 8 13
13 3 and 8 33
14 1 and 2 and 3 246
15 4 and 5 and 8 168
16 1 and 2 and 4 and 9 835
17 or/11–16 1133
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18 limit 17 to (human and english language and yr="2001 -Current") 917
19 conference.so. 2,063,092
20 limit 19 to yr="1902 - 2013" 1,554,910
21 18 not 20 846
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1 newborn intensive care unit.mp. or exp Intensive Care Units, Neonatal/ 10,996
2 exp Infant, Premature/ or extreme$ preterm infant.mp. or exp Gestational 
Age/ or exp Infant, Low Birth Weight/
122,948
3 *"Severity of Illness Index"/ or exp Infant, Premature/ or *Infant, 
Newborn/ or Score for Neonatal Acute Physiology.mp. or exp Intensive 
Care Units, Neonatal/
94,251
4 (SNAP or SNAP-II or SNAPPE-II).mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, keyword heading word, 
protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier]
7732
5 exp Patient Discharge/mt, og, st, sn, td [Methods, Organization & 
Administration, Standards, Statistics & Numerical Data, Trends]
5921
6 (guideline$ or factor$).mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, 
unique identifier]
4,479,794
7 (Benchmarking or Quality Control).mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, keyword heading word, 
protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier]
75,144
8 (Projection$ or Prediction$).mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol 




10 5 and 9 2631
11 2 and 5 and 6 54
12 1 and 2 and 4 38
13 2 and 10 54
Page 66 of 83
URL: http://mc.manuscriptcentral.com/djmf  Email: direnzo@unipg.it





























































For Peer Review Only
PREMII Development
14 1 and 5 and 6 33
15 3 and 5 142
16 or/11–15 190
17 limit 16 to (English language and humans and yr="2001 -Current") 144
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Supplementary Table 3. Overview of clinical expert interview questions.
Question 1 What is the average length of stay in your NICU for extremely premature 
infants? Near their due date? Or after their due date?
 What percentage of premature infants treated at your NICU are 
discharged home? To other departments in the hospital? Other?
 What are the readmission rates of these babies?






Question 2 How do you determine when an extremely premature infant can be 
discharged from the NICU?
 What physical factors are considered in the decision? 
 What other nonphysical factors are considered in the decision? 
 Do you rely on any guidelines when assessing an extremely premature 
infant’s readiness for NICU discharge?
Question 3 Do factors considered vary when assessing the physical readiness of an 
extremely premature infant versus mid or late preterm infant? If yes, how 
so?
Question 4 Based on your own individual practice, what are the FIVE most important 
criteria of those you listed used to determine if an infant is physically ready 
to be discharged from the NICU?
Question 5 Do you use any assessment tools in making the decision? Please describe 
each.
Question 6 Is there anything else important for us to know in designing a measure to 
assess physical readiness for discharge?
Question 7 Do you think physical readiness is an important outcome to measure? Do 
you think physical readiness is predictive of length of stay?
NICU: neonatal intensive care unit.
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Supplementary Table 4. Measures assessing infant morbidity and mortality risk (n = 3).
Author Instrument Primary outcome Relevant factors
Score for Neonatal Acute 
Physiology (SNAP-II) and SNAP-
Perinatal Extension Version II 
(SNAPPE-II)
In-hospital mortality Birth weight; Apgar score at 
birth; 5-min Apgar score; GA; 
size for GA
Clinical Risk Index for Babies 
(CRIB)
Mortality and morbidity —
Richardson 2001 
[1]
Pediatric Risk of Mortality 
(PRISM)
Mortality —
Robison 2000a [2] Neonatal Discharge Assessment 
Tool (N-DAT)
Identification of areas of need Medical need: postoperative 
care, nutritional issues, 
medications, and behavioral and 
developmental implications
Bender 2013 [3] Morbidity Assessment Index for 
Newborns (MAIN)
Morbidity —
aStudy published before 2001 cutoff date, but included due to the high relevance to the subject of inquiry. 
GA: gestational age.
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Supplementary Table 5. Country-specific guidelines (n = 2) and clinical expert opinion (n = 3) on assessment of physical discharge readiness 







Oral feeding to 
support growth Thermoregulation Additional factors
United 
States [4]
Yes Yes Yes Yes
Immunizations; metabolic screening; 
hematologic status; nutritional risk assessment; 
hearing evaluation; funduscopic exam; 
neurodevelopmental/neurobehavioral status; car 
seat evaluation; environmental factors
Canada [5] Yes Yes Yes Yes
Immunizations; provincial newborn screening; 
assessment for RSV prophylaxis and 
administration; cranial imagining at near term; 
ROP screening; hearing evaluation; car seat 
evaluation; predischarge physical exam
Argentinaa
Yes Yes Yes Yes
Nutritional risk assessment; inguinal hernia 
assessment
Europeb Yes Yes Yes Yes
Stable laboratory parameters (e.g., SaO2, 
acid/base/electrolyte balance); gestational age
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Germanyb NR NR NR NR
No official guideline on discharge of preterm 
neonates; only specific guidelines addressing 
specific topics (e.g., necrotizing enterocolitis, 
primary care after delivery)
aTranslated by ICON. ICON is a contract research organization providing a range of drug development services globally to the pharmaceutical, 
biotechnology, and medical device industries. The company specializes in the strategic development, management, and analysis of programs that 
support clinical development from compound selection to phase 1–4 clinical studies. The headquarters are in Dublin, Ireland, and ICON 
currently operates from 93 locations in 37 countries and has ~13,675 employees. 
bPer communication with ICON Clinical Research.
NICU: neonatal intensive care unit; NR: not reported; ROP: retinopathy of prematurity; RSV: respiratory syncytial virus; SaO2: oxygen 
saturation. 
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Supplementary Table 6. Participant characteristics for the clinical expert review, Delphi panel survey, and cognitive interview development 












Online clinician survey 
(n = 201)
Characteristic
Specialty, n Specialty, n Specialty, n Specialty, n Specialty, n
Neonatologist 4 Neonatologist 17 NICU nurse 18 NICU nurse 9 Pediatrics 136
Neonatologist 5 Neonatologist 65
Country, n Country, n Country, n Country, n Country, n




Germany 2 Canada 3 United 
Kingdom
4 Japan 31
United States 2 Australia 1 Japan 3 Mexico 16
Brazil 1 United Kingdom 3 Australia 13
Canada 1 United States 3 Brazil 13
France 1 Brazil 2 Canada 13
Israel 1 Germany 2 Colombia 12
Japan 1 The Netherlands 2 United 
Kingdom
12
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The Netherlands 1 Poland 1 France 10
Mexico 1 Spain 1 Germany 10
Poland 1 Italy 10
Spain 1 Argentina 9





NICU: neonatal intensive care unit; PREMII: PREMature Infant Index.
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Supplementary Figure 1. Respondent preferences for calculating daily individual factor 
scores for use in the PREMII: findings from the online clinician survey (n = 201). 
Respondents were presented with example individual factor ratings for each shift over a 24-h 
period and then asked to indicate the most appropriate method (most frequent, numerical 
average, worst [or best, as applicable], most recent, or other) to calculate a daily factor score 
from the shift ratings to accurately capture functional status. aAll ≤2.5%. Note: weight gain 
was excluded from this measurement due to weight not being measured repeatedly across 
shifts. PREMII: PREMature Infant Index.
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Supplementary Figure 2. Relative importance of PREMII factors in rating overall functional 
status: findings from the online clinician survey (n = 201). 
Respondents rated the importance of each factor on a scale from 1 (most important) to 8 
(least important) when rating overall functional status and were allowed to provide the same 
rating for multiple factors. Results for relative importance rated ≤4 are not shown. PREMII: 
PREMature Infant Index.
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PREMature Infant Index Questionnaire 
Instructions: 
• To be completed by the NICU nurse near the end of his or her shift, for each infant during the study period, in accordance with the study 
schedule.  
• For each question, select one response that reflects the WORST experience observed for the infant during your shift.   
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Report the GREATEST level of support during your shift 
Mechanical ventilation with endotracheal or tracheostomy tube or 
mask   □ □ □ □ 
Respiratory pressure support [for example: high flow (≥2 L/min or 
≥2000 cc/min) nasal cannula, nCPAP] □ □ □ □ 
Supplemental oxygen continuously not through a nasal cannula  □ □ □ □ 
Continuous low flow (<2 L/min or <2000 cc/min) nasal cannula  □ □ □ □ 
[If “Continuous low flow (<2 L/min or <2000 cc/min) nasal 























□ Air flow 
meter 
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[If L/min selected above] 
 
Please enter the greatest setting:   
 
[If cc/min selected above] 
 





























































Supplemental oxygen but not continuously OR pulmonary 
medication administered (for example: diuretics, inhaled steroids, 
or inhaled bronchodilators)  
□ □ □ □ 
No supplemental oxygen AND no pulmonary medication 
administered (for example: diuretics, inhaled steroids, or inhaled 
bronchodilators)   
□ □ □ □ 
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For this shift, a desaturation event is defined as ≤: _____% ____% ____% ____% 
Enter the total number of the following events, if any, that 
occurred during your shift: 
Apnea 
• Event(s) that required intervention (for example: 
increasing oxygen, physical or mechanical stimulation, 
initiating compressions, bag mask ventilation) 



















































 Report the HIGHEST concentration during your shift 
[Skip if “Continuous low flow (<2 L/min or <2000 cc/min) nasal cannula” selected for Respiratory Support] 
61% or greater  □ □ □ □ 
51–60%  □ □ □ □ 
41–50% □ □ □ □ 
31–40%  □ □ □ □ 
22–30%  □ □ □ □ 
21% (room air or no additional oxygen administered) □ □ □ □ 
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• Event(s) that required intervention (for example: 
increasing oxygen, physical or mechanical stimulation, 
initiating compressions, bag mask ventilation) 




• Event(s) that required intervention (for example: 
increasing oxygen, physical or mechanical stimulation, 
initiating compressions, bag mask ventilation) 














































































Select one response that reflects the WORST experience for the infant during your shift 
Infant was in a closed and heated incubator OR was under a 
radiant warmer □ □ □ □ 
Infant was in an open bassinet or cot and required additional 
support to stay warm (for example: multiple blankets, a heated 
mattress) 
□ □ □ □ 
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Infant was in an open bassinet or cot and did NOT require 







Did any feeds [including intravenous nutrition (solution containing 










[If “Yes” selected above, complete below; if “No” selected above, skip to Weight] 
Select one response that reflects the WORST experience for the infant during your shift 
Any intravenous nutrition (solution containing amino acids or 
lipids) OR all feeds by enteral feeding tube (no breast or bottle) □ □ □ □ 
Some portion of feeds by enteral feeding tube AND some by 
breast or bottle but WITH a problem breathing or swallowing □ □ □ □ 
Some portion of feeds by enteral feeding tube AND some by 
breast or bottle but WITHOUT any problems breathing or 
swallowing  
□ □ □ □ 
All feeds by breast or bottle (no enteral feeding tube) but WITH a 
problem breathing or swallowing □ □ □ □ 
All feeds by breast or bottle (no enteral feeding tube) WITHOUT 
any problems breathing or swallowing but at least one feed took 
LONGER THAN 30 MINUTES 
□ □ □ □ 
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7 
  
All feeds by breast or bottle (no enteral feeding tube) WITHOUT 
any problems breathing or swallowing and all feeds took 30 
MINUTES OR LESS 






[Complete ONLY for first administration for a given infant] 
 
Enter last recorded weight prior to your shift. Please round to the 
nearest whole number: 
 
Date (DD-MMM-YYYY; for example: 01-JAN-2017): 
 

















[If “Yes” selected above] 
 
Enter lowest recorded weight during your shift. Please round to 
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